We're hosting events nationwide (and virtually) to tackle the biggest questions in health and medicine.
"STAT Summits connect you with today's innovators and tomorrow's thought leaders"
Jason Lippman Solutions, LLC
Browse our upcoming events — or see the full list of industry events and other STAT events we have scheduled.
2021 STAT Summit
Join us for our signature STAT Summit event. As we gather the top minds in the life sciences, we'll bring to life the coverage that has earned STAT its reputation: deep analysis and fearless discussion around the most important topics in biotech, medicine, and policy, brought to you by the industry's top talent.
Can tech improve healthcare’s value proposition?
Coming off the success of Livongo, Glen Tullman, now the CEO of Transcarent, has new ideas for revamping employer-based health. Come to hear them.
CAR-T comes of age?
CAR-T is still a therapy used mostly as a last resort. Could new clinical trials that are about to report out in full change that? STAT's Adam Feuerstein gathers experts to look ahead.
Delving into digital biomarkers
We take a look at the wearable, portable and digestible technologies shaping the future of healthcare, from tracking blood oxygen levels with smartwatches to detecting Parkinson’s symptoms with mobile phones.
TYPES OF EVENTS
We have something for everyone. Get in touch with us to learn how to sponsor an upcoming event.
When circumstances permit, we host multiple in-person events per year for STAT readers and subscribers around the country.View Upcoming Events
Join us for our online events featuring industry experts and deep-dive webinars on industry trends.View Upcoming Virtual Events
Ranging from half-day to multi-day programming, and bringing the biggest names in biopharma, policy, and technology to the stage.View Upcoming Summit
Take a peek at past events, and access session recordings if you weren’t able to join us live.
The 2021 STAT Breakthrough Science Summit
Technologies and procedures that would have been science fiction are now the reality of medicine. Our 2021 STAT Breakthrough Science Summit took attendees inside these innovations, examining how they're being developed, adopted, and paid for. We also explored the breakthroughs that haven't yet hit the market, but have the potential to redefine health and medicine in the years to come.
The evolving landscape for biosimilars
Biosimilars were anticipated to be a solution to the soaring cost of prescription medicines to treat a slew of diseases. Have they reached their potential? Some see encouraging signs of increased adoption rates for these treatments, which are made from living cells and nearly identical to their biologic counterparts. Others fear they are meeting resistance.
STAT+ Conversation: What's next in gene therapy
The first gene therapies -- treatments that aim to replace missing genes -- have hit the market, and many more are due soon. STAT's Damian Garde and Matthew Herper looked at new potential treatments for diseases ranging from sickle cell anemia to muscular dystrophy.
2021 STAT Health Tech Summit
Biology and technology are converging to change medicine. The 2021 STAT Health Tech Summit brought together experts working at the intersection of tech and health care — at both Silicon Valley giants and upstarts just emerging from stealth — as they continue to design the future of health.
Receive a monthly newsletter about upcoming events and promotions from STAT and our partners.